Examining PTSD prevalence in adults with Type 1 Diabetes
Prevalence of Post Traumatic Stress Disorder Related to Diabetes Diagnosis or Severe Hypoglycaemia in Adult With Type 1 Diabetes
This study looks at how common PTSD is among adults with Type 1 Diabetes and how it affects their quality of life and mental health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospital St. Joseph, Marseille, France Academic / other |
| Locations | 2 sites (Marseille and 1 other locations) |
| Trial ID | NCT05662657 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the prevalence of Post Traumatic Stress Disorder (PTSD) among adults diagnosed with Type 1 Diabetes, particularly focusing on the impact of severe hypoglycemia and the diabetes diagnosis itself. The study aims to assess how these factors affect the quality of life, sleep, and mental health of patients. Participants will complete the PCL-S Questionnaire to evaluate their PTSD symptoms. The research is conducted in France, targeting a population of approximately 185,000 adults living with Type 1 Diabetes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with Type 1 Diabetes and can complete questionnaires in French.
Not a fit: Patients who are not diagnosed with Type 1 Diabetes or those with unstable psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the mental health challenges faced by patients with Type 1 Diabetes, leading to improved support and treatment strategies.
How similar studies have performed: While studies have explored the psychological impacts of chronic conditions, this specific focus on PTSD related to diabetes and hypoglycemia is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older, * With type 1 diabetes, * Willing and able to complete all the questionnaires in French, * Who have given oral consent, * being affiliated to a social security scheme or being a beneficiary of such a scheme. Exclusion Criteria: * Non-diabetic type 1, * With an unstable psychiatric pathology, * Pregnant or breastfeeding women, * Subject to a measure for the protection of justice, * Having opposed the research.
Where this trial is running
Marseille and 1 other locations
- Hopital Saint Joseph — Marseille, France (Recruiting)
- Centre Hospitalier de Martigues — Martigues, France (Not_yet_recruiting)
Study contacts
- Study coordinator: Rahamia AHAMADA
- Email: rahamada@hopital-saint-joseph.fr
- Phone: 0488731071
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.